Oct 27 (Reuters) - Britain's GSK beat analysts'
expectations for third-quarter earnings on Wednesday and raised
its outlook for annual profit ahead of a planned split next
year.
The company now expects 2021 adjusted earnings per share to
decline by between 2% and 4% at constant exchange rates,
excluding any boost from its COVID-19 offerings. It previously
expected profit to fall by mid-to-high single digit percentages.
(Reporting by Pushkala Aripaka in Bengaluru and Ludwig Burger
in Frankfurt; editing by Jason Neely)